Pneumocystis pneumonia has a poor prognosis and a high mortality rate.Treatment outcome varies depending on whether the patient has HIV or not, and generally mortality is higher in non-AIDS patients.
Pneumocystis can be spread by airborne droplets from patients with Pneumocystis pneumonia or from carriers of Pneumocystis. However, given the rarity of Pneumocystis causing pneumonia in immunocompetent populations, the risk…
There is no vaccine available to prevent Pneumocystis pneumonia, but it can be prevented in patients with HIV or other immunosuppressed patients by using medications such as compound sulphamethoxazole.
The drug of choice for Pneumocystis pneumonia is cotrimoxazole, and if cotrimoxazole is poorly treated, other drugs such as pentazocine and aminophenazone may be chosen.